These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1345886)

  • 21. Effect of the beta-adrenoceptor agonist BRL 26830 on fatty acid synthesis and on the activities of pyruvate dehydrogenase and acetyl-CoA carboxylase in adipose tissues of the rat.
    Wilson S
    Biosci Rep; 1989 Feb; 9(1):111-7. PubMed ID: 2566340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of BRL 26830, a novel beta-adrenoceptor agonist, on glucose tolerance, insulin sensitivity and glucose turnover in Zucker (fa/fa) rats.
    Smith SA; Levy AL; Sennitt MV; Simson DL; Cawthorne MA
    Biochem Pharmacol; 1985 Jul; 34(14):2425-9. PubMed ID: 2861816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compound M & B 39890A [N-(3-imidazol-1-ylpropyl)- 2-(3-trifluoromethylbenezensulphonamido)-benzamide hydrochloride], a glucagon and insulin secretion inhibitor, improves insulin sensitivity in viable yellow obese-diabetic mice.
    Yen TT; Schmiegel KK; Gold G; Williams GD; Dininger NB; Broderick CL; Gill AM
    Arch Int Pharmacodyn Ther; 1991; 310():162-74. PubMed ID: 1772327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of (-)-(R)-1-(p-hydroxyphenyl)-2-[3,4-dimethoxyphenethyl)amino]ethanol (TA-064), a new cardiotonic agent, on circulating parameters of carbohydrate and lipid metabolism in the rat.
    Inamasu M; Totsuka T; Morita T; Takeyama S
    Biochem Pharmacol; 1984 Jul; 33(14):2171-7. PubMed ID: 6147139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-3 adrenergic agonist, BRL-26830A, and alpha/beta blocker, arotinolol, markedly increase regional blood flow in the brown adipose tissue in anesthetized rats.
    Takahashi H; Yoshida T; Nishimura M; Nakanishi T; Kondo M; Yoshimura M
    Jpn Circ J; 1992 Sep; 56(9):936-42. PubMed ID: 1383578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activities of enzymes of glycerolipid synthesis in brown adipose tissue after treatment of rats with the adrenergic agonists BRL 26830A and phenylephrine, after exposure to cold and in streptozotocin-diabetes.
    Mitchell JR; Saggerson ED
    Biochem J; 1991 Aug; 277 ( Pt 3)(Pt 3):665-9. PubMed ID: 1678597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of beta-sitosterol-3-beta-D-glucoside on insulin secretion in vivo in diabetic rats and in vitro in isolated rat islets of Langerhans.
    Ivorra MD; Paya M; Villar A
    Pharmazie; 1990 Apr; 45(4):271-3. PubMed ID: 2200064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of hydrocortisone on terbutaline stimulated insulin release from isolated pancreatic islets.
    Chuthaputti A; Fletcher HP
    Res Commun Chem Pathol Pharmacol; 1987 Sep; 57(3):329-41. PubMed ID: 2823354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extract isolated from Angelica hirsutiflora with insulin secretagogue activity.
    Leu YL; Chen YW; Yang CY; Huang CF; Lin GH; Tsai KS; Yang RS; Liu SH
    J Ethnopharmacol; 2009 Jun; 123(2):208-12. PubMed ID: 19429364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of alpha- and beta-adrenoceptor stimulation on 45Ca2+ efflux and insulin secretion from perfused rat islets.
    Ahrén B; Lundquist I
    Acta Physiol Scand; 1985 Jul; 124(3):381-9. PubMed ID: 2864777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychological aspects of dietary weight loss and medication with the atypical beta agonist BRL 26830A in obese subjects.
    MacLachlan M; Connacher AA; Jung RT
    Int J Obes; 1991 Jan; 15(1):27-35. PubMed ID: 1672679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β3-adrenoceptor-mediated increased circulating transaminase levels in mice treated with its agonist BRL 37344.
    Kasahara H; Muto S; Motokawa Y; Arisaka N; Kobayashi S; Souma S; Kuroda J
    J Toxicol Sci; 2010 Oct; 35(5):779-84. PubMed ID: 20930473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats.
    Meidute Abaraviciene S; Muhammed SJ; Amisten S; Lundquist I; Salehi A
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):150-9. PubMed ID: 23911664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cells.
    Moran BM; Abdel-Wahab YH; Flatt PR; McKillop AM
    Diabetes Obes Metab; 2014 Nov; 16(11):1128-39. PubMed ID: 24919766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat pancreatic islets.
    Niddam R; Angel I; Bidet S; Langer SZ
    J Pharmacol Exp Ther; 1990 Sep; 254(3):883-7. PubMed ID: 1975625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell.
    Vieira E; Liu YJ; Gylfe E
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):179-83. PubMed ID: 14727006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased insulin binding and glucose transport in white adipocytes isolated from C57B1/6 ob/ob mice treated with the thermogenic beta-adrenoceptor agonist BRL 26830.
    Young P; King L; Cawthorne MA
    Biochem Biophys Res Commun; 1985 Dec; 133(2):457-61. PubMed ID: 2867764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in adrenergic recognition by pancreatic A and B cells.
    Schuit FC; Pipeleers DG
    Science; 1986 May; 232(4752):875-7. PubMed ID: 2871625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion.
    Yoshida S; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Sep; 400(3):437-41. PubMed ID: 20804735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.